L-Glutamine-d5
(Synonyms: L-谷氨酰胺-2,3,3,4,4-D5,L-Glutamic acid 5-amide-d5) 目录号 : GC49377An internal standard for the quantification of L-glutamine
Cas No.:14341-78-7
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
L-Glutamine-d5 is intended for use as an internal standard for the quantification of L-glutamine by GC- or LC-MS. L-Glutamine is a non-essential amino acid involved in many biochemical processes. It is synthesized in vivo by glutamate and ammonia.1 It serves as a substrate for glutamine synthetase in neurons for the biosynthesis of the major excitatory and inhibitory neurotransmitters glutamate and GABA.2 L-Glutamine decreases adhesion of sickle red blood cells (RBCs) to human umbilical vein endothelial cells (HUVECs) when incubated ex vivo with patient-derived autologous plasma either alone or with LPS.3 It has commonly been used in cell culture media. Formulations containing L-glutamine have been used in the treatment of sickle cell disease.
1.Eisenberg, D., Gill, H.S., Pfluegl, G.M.U., et al.Structure-function relationships of glutamine synthetasesBiochim Biophys. Acta.1477(1-2)122-145(2000) 2.Bak, L.K., Schousboe, A., and Waagepetersen, H.S.The glutamate/GABA-glutamine cycle: Aspects of transport, neurotransmitter homeostasis and ammonia transferJ. Neurochem.98(3)641-653(2006) 3.Niihara, Y., Matsui, N.M., Shen, Y.M., et al.L-glutamine therapy reduces endothelial adhesion of sickle red blood cells to human umbilical vein endothelial cellsBMC Blood Disord.5(4)(2005)
Cas No. | 14341-78-7 | SDF | |
别名 | L-谷氨酰胺-2,3,3,4,4-D5,L-Glutamic acid 5-amide-d5 | ||
Canonical SMILES | NC(C([2H])([2H])C([2H])([2H])[C@]([2H])(N)C(O)=O)=O | ||
分子式 | C5H5D5N2O3 | 分子量 | 151.2 |
溶解度 | H2O : 12.5 mg/mL (82.68 mM; Need ultrasonic) | 储存条件 | -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 6.6138 mL | 33.0688 mL | 66.1376 mL |
5 mM | 1.3228 mL | 6.6138 mL | 13.2275 mL |
10 mM | 0.6614 mL | 3.3069 mL | 6.6138 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。